SCIENCE MANAGEMENT CORP /NJ/
10-Q, 1997-08-19
MANAGEMENT CONSULTING SERVICES
Previous: SCAN OPTICS INC, SC 13D/A, 1997-08-19
Next: SCUDDER INTERNATIONAL FUND INC, PRES14A, 1997-08-19







                                 UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D. C.  20549

                                  FORM 10-Q


(Mark One)
[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934.

For the Quarterly Period Ended June 30, 1997  Commission File Number 1-6059 
                              ---------------                       --------


                        SCIENCE MANAGEMENT CORPORATION         
- -------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)

             DELAWARE                                   21-0692362         
- -------------------------------------    --------------------------------------
  (State or other jurisdiction of        (I.R.S. Employer Identification No.)
   incorporation or organization)

         721 Routes 202-206
       Bridgewater, New Jersey                             08807         
- ----------------------------------------  -------------------------------------
(Address of principal executive offices)                (Zip Code)

Registrant's telephone number, including area code          (908) 722-0300     
                                                  -----------------------------


                               Not Applicable                   
- -------------------------------------------------------------------------------
                   (Former name, former address and former 
                  fiscal year, if changed since last report.)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                              Yes      No  X 
                                 -----   -----

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practical date.

    Class of Common Stock               Outstanding at July 31, 1997  
    ---------------------               ----------------------------
        $ .10 par value                      2,000,000 shares


<PAGE>


              SCIENCE MANAGEMENT CORPORATION AND SUBSIDIARIES

                            INDEX TO FORM 10-Q

                                                                          PAGE
                                                                          ----
<TABLE>
<CAPTION>
   <S>                                                                   <C>

   PART I - FINANCIAL INFORMATION

      ITEM 1 - Financial Statements

               Consolidated Balance Sheets as of
               June 30, 1997 and December 31, 1996.                         3

               Consolidated Statements of Operations for the
               Three-Month and Six-Month Periods Ended
               June 30, 1997 and 1996.                                      4

               Consolidated Statements of Cash Flows
               for the Six-Month Periods Ended
               June 30, 1997 and 1996.                                      5
               
               Notes to Consolidated Financial Statements                 6-7

      ITEM 2 - Management's Discussion and Analysis
               of Financial Condition and Results of Operations           8-9


   PART II - OTHER INFORMATION

      ITEM 1 - Legal Proceedings                                            10

      ITEM 5 - Other Information                                         10-11

      ITEM 6 - Exhibits and Reports on Form 8-K                             11

   SIGNATURES                                                               12
</TABLE>

<PAGE>



              SCIENCE MANAGEMENT CORPORATION AND SUBSIDIARIES
                        Consolidated Balance Sheets
                        (Unaudited - in thousands)


<TABLE>
<CAPTION>
                                                    June 30,      December 31,
                                                      1997            1996
                                                    --------      ------------

<S>                                                 <C>             <C>
ASSETS                                 
  Current assets
    Cash. . . . . . . . . . . . . . . . . . .       $    342        $    406 
    Accounts receivable, net. . . . . . . . .          5,280           3,633 
    Prepaid and other current assets. . . . .            148             165 
                                                    ---------       ---------
      Total current assets. . . . . . . . . .          5,770           4,204 
  
  Property and equipment, net . . . . . . . .            371             409 
  Other assets. . . . . . . . . . . . . . . .             62              86 
  Intangible. . . . . . . . . . . . . . . . .          1,028           1,077 
                                                    ---------       ---------
      Total assets. . . . . . . . . . . . . .       $  7,231        $  5,776 
                                                    =========       =========

LIABILITIES AND STOCKHOLDERS' EQUITY
  Current liabilities
    Accounts payable. . . . . . . . . . . . .       $  2,408        $  1,736 
    Accrued payroll and vacation. . . . . . .            164             136 
    Other liabilities . . . . . . . . . . . .          1,801           1,124 
                                                    ---------       ---------
      Total current liabilities . . . . . . .          4,373           2,996 

  Liabilities from reorganization plan. . . .          1,010           1,123 
                                                    ---------       ---------
      Total liabilities . . . . . . . . . . .          5,383           4,119 

  Stockholders' equity
    Preferred stock, $1 par value, 
     1,750,000 shares authorized
     and outstanding. . . . . . . . . . . . .          1,750           1,750 
    Common stock , $.10 par value;
     5,000,000 shares authorized
     and 2,000,000 shares outstanding . . . .            200             200
    Capital in excess of par value. . . . . .             14              14 
  Accumulated deficit . . . . . . . . . . . .           (116)           (307)
                                                    ---------       ---------
      Total stockholders' equity. . . . . . .          1,848           1,657 
                                                    ---------       ---------

      Total liabilities and
       stockholders' equity . . . . . . . . .       $  7,231        $  5,776 
                                                    =========       =========
</TABLE>

                                    
                     The accompanying notes are an integral
                part of these consolidated financial statements.

                                      3
<PAGE>


             SCIENCE MANAGEMENT CORPORATION AND SUBSIDIARIES
                  Consolidated Statements of Operations
          (Unaudited - in thousands, except per share amounts)

<TABLE>
<CAPTION>
                     For theThree-Month                For the Six-Month
                    Periods Ended June 30,            Periods Ended June 30, 
                    ----------------------            ----------------------
                    1997            1996              1997            1996    
                    ----            ----              ----            ----

<S>                              <C>         <C>         <C>         <C>
GROSS REVENUE . . . . . . . . .  $  6,555    $  6,453    $ 12,429    $ 12,438 
Purchased services and
 materials, at costs. . . . . .     3,444       2,382       5,982       4,556 
                                 ---------   ---------   ---------   ---------
NET SERVICE REVENUE . . . . . .     3,111       4,071       6,447       7,882 

Direct costs of services
 and overhead . . . . . . . . .     1,826       2,469       3,838       5,054 
Selling, general and
 administrative expenses. . . .     1,087       1,530       2,400       2,981 
                                 ---------   ---------   ---------   ---------
OPERATING INCOME. . . . . . . .       198          72         209        (153) 

OTHER EXPENSE
Interest (income) expense . . .       ---          (4)        ---          43 
Income tax expense. . . . . . .        18         216          18         216 
                                 ---------   ---------   ---------   ---------

NET INCOME (LOSS) . . . . . . .  $    180    $   (140)   $    191    $   (412)
                                 =========   =========   =========   =========

NET INCOME (LOSS) PER SHARE . .  $    .09    $   (.04)   $    .10    $   (.12)
                                 =========   =========   =========   =========

WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING. . . . . . .     2,000       3,300       2,000       3,300 
                                 =========   =========   =========   =========
</TABLE>



                        The accompanying notes are an integral
                   part of these consolidated financial statements.

                                           4

<PAGE>


             SCIENCE MANAGEMENT CORPORATION AND SUBSIDIARIES
                  Consolidated Statements of Cash Flows
                       (Unaudited - in thousands)

<TABLE>
<CAPTION>
                                                        For the Six-Month
                                                      Periods Ended June 30,
                                                      ----------------------
                                                        1997          1996    
                                                        ----          ----

<S>                                                  <C>           <C> 
Cash flows from operating activities
 Net income . . . . . . . . . . . . . . . . .        $    191      $    412 
 Adjustments to reconcile net income to
  net cash used in operating activities
      Depreciation and amortization . . . . .             132           200 
      Provision for doubtful accounts
       receivable . . . . . . . . . . . . . .            (106)           20 
                                                     ---------     ---------
         Subtotal . . . . . . . . . . . . . .             217           632 

 Changes in assets and liabilities,
  net of asset dispositions
      (Increase) decrease in accounts
       receivable . . . . . . . . . . . . . .          (1,542)        1,701 
      Decrease (increase) in prepaids
       and other assets . . . . . . . . . . .              41           (49)
      Increase (decrease) in accounts
       payable. . . . . . . . . . . . . . . .             672          (979)
      Increase (decrease) in accrued 
       salaries and vacation. . . . . . . . .              28          (462)
      Decrease in other liabilities . . . . .             (25)       (3,090)
                                                     ---------     ---------
         Net cash used in operating
          activities. . . . . . . . . . . . .            (609)       (2,247)
                                                     ---------     ---------

Cash flows from investing activities
 Purchase of property and equipment . . . . .             (46)          (34)
                                                     ---------     ---------

Cash flows from financing activities
 Net borrowings on notes payable. . . . . . .             ---           173 
 Principal payments on long-term debt . . . .            (113)          --- 
 Proceeds from Versar . . . . . . . . . . . .             704           --- 
                                                     ---------     ---------
         Net cash provided by financing
          activities. . . . . . . . . . . . .             591           173 


Net decrease in cash. . . . . . . . . . . . .             (64)       (2,108)
Cash at the beginning of the year . . . . . .             406         2,227 
                                                     ---------     ---------

Cash at the end of the period . . . . . . . .        $    342      $    119 
                                                     =========     =========

Supplementary disclosure of cash flow information:
 Cash paid during the period for
  Interest. . . . . . . . . . . . . . . . . .        $      0      $     43 
  Income taxes. . . . . . . . . . . . . . . .               0             0 
</TABLE>



                   The accompanying notes are an integral
         part of these condensed consolidated financial statements.

                                      5

<PAGE>



             SCIENCE MANAGEMENT CORPORATION AND SUBSIDIARIES
               Notes to Consolidated Financial Statements
                                    
(A)  Basis of Presentation

     The accompanying consolidated financial statements are presented in
accordance with the requirements of Form 10-Q and consequently do not include
all of the disclosures normally required by generally accepted accounting
principles or those normally made in Science Management Corporation ("SMC" or
the "Company") Annual Report on Form 10-K.  The Company has not made any
public filings since November 23, 1994 due to bankruptcy proceedings under
Chapter 11.  The Company has subsequently emerged from Chapter 11 on July 10,
1996.  All financial statements presented have not been audited.

     The financial information has been prepared in accordance with the
Company's customary accounting practices.  In the opinion of management, the
information reflects all adjustments necessary for a fair presentation of the
Company's consolidated financial position as of June 30, 1997, and the results
of operations for the six-month periods ended June 30, 1997 and 1996.  The
results of operations for such periods, however, are not necessarily
indicative of the results to be expected for a full fiscal year.

(B)  Accounting Estimates

     The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period.

(C)  Contract Accounting

     Contracts in process are stated at the lower of actual cost incurred
plus accrued profits or net estimated realizable value of incurred costs,
reduced by progress billings.  The Company records income from major fixed-
price contracts, extending over more than one accounting period, using the
percentage-of-completion method.  During performance of such contracts,
estimated final contract prices and costs are periodically reviewed and
revisions are made as required.  The effects of these revisions are included
in the periods in which the revisions are made.  On cost-plus-fee contracts,
revenue is recognized to the extent of costs incurred plus a proportionate
amount of fee earned, and on time-and-material contracts, revenue is
recognized to the extent of billable rates times hours delivered plus material
and other reimbursable costs incurred.  Losses on contracts are recognized in
the period in which they become known.  Disputes arise in the normal course of
the Company's business on projects where the Company is contesting with
customers for collection of funds because of events such as delays, changes in
contract specifications and questions of cost allowability or collectibility. 
Such disputes, whether claims or unapproved change orders in the process of
negotiation, are recorded at the lesser of their estimated net realizable
value or actual costs incurred and only when realization is probable and can
be reliably estimated.  Claims against the Company are recognized where loss
is considered probable and is reasonably determinable in amount.

     It is the Company's policy to provide reserves for the collectibility of
accounts receivable when it is determined that it is probable that the Company
will not collect all amounts due and the amount of reserve requirements can be
reasonably estimated.

                                       6

<PAGE>



           SCIENCE MANAGEMENT CORPORATION AND SUBSIDIARIES
         Notes to Consolidated Financial Statements (continued) 
                                    
(D)  Contingencies

     SMC and its subsidiaries are parties to various legal actions arising in
the normal course of business.  The Company believes that the ultimate
resolution of these legal actions will not have a material adverse effect on
its consolidated financial condition and results of operations.

(E)  Net Income Per Share

     Net income per share is computed by dividing net income by the weighted
average number of common shares outstanding during the applicable period being
reported.

(F)  Common and Preferred Stock

     Pursuant to SMC's Plan of Reorganization (the "Plan"), which was
confirmed by the U.S. Bankruptcy Court on April 17, 1996, and became effective
on July 10, 1996, all of the common stock of Science Management Corporation,
outstanding as of July 10, 1996 (the "Old Common Stock"), was cancelled.  As
provided by the terms of the Plan, holders of Old Common Stock, the holders of
unsecured claims allowed by the Court in the Chapter 11 proceeding, and
certain members of the Company's management, received distributions of new
common shares of SMC ("New Common Stock").  In addition, and as described in
the Plan, Imperial Capital Worldwide Partners, the holder of the largest
secured claim against SMC, received a distribution of New Common Stock
together with a distribution of 1,750,000 shares of Science Management
Corporation Preferred Stock, with a par value of $1.00 per share and
redeemable by the Company subject to conditions and restrictions contained in
the Plan.

     The total number of Old Common Stock cancelled pursuant to the Plan was
3,300,000 shares.  A total of 5,000,000 shares of New Common Stock, par value
$0.10 per share, were authorized under the Plan, with issuance as described
above on July 10, 1996, of a total of 2,000,000 shares.

(G)  Subsequent Event

     Effective April 30, 1997, Versar, Inc. ("Versar") acquired 53% of the
outstanding common stock and all outstanding preferred stock of Science
Management Corporation ("SMC") for aggregate consideration of $2,870,000 in
cash.  Versar intends to propose a merger pursuant to which Versar will obtain
the remaining SMC common stock for newly issued shares of Versar common stock,
subject to SMC stockholder approval.  (See Item 5 - "Other Information" for
further details.)

                                     7

<PAGE>


ITEM 2    Management's Discussion and Analysis of Financial Condition and
          Results of Operations

Results of Operations
- ---------------------

First Six Months and Second Quarter 1997 Compared to 1996
- ---------------------------------------------------------

     Gross revenue for the first half of 1997 was virtually unchanged from
the first six months of 1996, despite the absence in the 1997 period of the
Company's former European subsidiaries, which collectively contributed $2.9
million in revenues during the first half of 1996.  This improvement came
about through significantly increased revenues in the Company's engineering
and construction business and domestic consulting business.  The engineering
and construction increase reflected strong second quarter 1997 sales on new
projects, compared with a relatively slow second quarter in 1996, while the
increase in the consulting business was driven by work received in February
1997.

     Gross revenue for the second quarter of 1997 increased $102,000 (2%)
over the comparable 1996 period.  This resulted from the strong sales in the
engineering and construction and consulting segments as noted above.  In
addition, the gross revenues in the second quarter of 1997 included revenues
of approximately $474,000 from SMC's current efforts to rebuild its European
business.  This significantly tempered the reduction of $947,000 of revenue
contributions during the second quarter of 1996 from the former European
businesses, which were sold in May 1996 in accordance with the Company's Plan
of Reorganization.

     Purchased services and materials increased by $1,426,000 (31%) and
$1,062,000 (45%) in the first six months and in the second quarter of 1997,
respectively, as compared to similar periods in 1996.  These increases
reflected the greater relative contribution from the engineering and
construction segments, with a higher level of direct pass-through costs
coupled with the use of contracted consultants in the current year.

     The $1,216,000 (24%) reduction in direct costs of services and overhead
for the first six months of 1997 compared with the first six months of 1996
resulted from lower direct salaries and wages in the environmental engineering
segment in the current year period along with the impact of the sale of SMC's
former European businesses in 1996.  This reduction reflected both the
decreased labor utilization in the environmental engineering in 1997 and the
impact of additional personnel on staff during the first quarter of 1996 to
fulfill a major design and construction project, which was concluded in April
1996.  The $643,000 (26%) decrease in this category for the second quarter of
1997 compared with the second quarter of 1996 resulted largely from the same
factors as mentioned above. 

     Selling, general, and administrative expenses decreased $581,000 (15%)
in the first six months and $443,000 (25%) in the second quarter of 1997 as
compared to similar periods in 1996.  This reduction reflected cost control
measures throughout the Company, led by reduced commercial insurance costs
through consolidation of the insurance program, as well as the impact of the
absence in 1997 of general and administrative expenses from the former
European businesses.

     The absence of interest expense in the current year resulted from the
satisfaction in May 1996 of a secured interest-bearing pre-petition claim on
the Company, satisfied through the sale of the former European subsidiaries.

     Income tax expense in 1996 resulted entirely from the former European
subsidiaries.

     SMC reported net income of $191,000 for the first six months and
$180,000 for the second quarter of 1997, compared with losses of $412,000 and
$140,000 in the respective periods of 1996.  The improvement is the result of
improved earnings in the consulting services and the engineering and
construction units, both of 

                                     8

<PAGE>



ITEM 2    Management's Discussion and Analysis of FinancialCondition and
          Results of Operations (continued)

which were profitable in the 1997 periods after reporting losses for the first
six months of 1996, complemented by increased profitability levels in the
business information systems unit.  These gains were offset in part by
continuing losses in the environmental unit, which has experienced significant
revenue declines primarily as a result of decreased environmental enforcement
activity in its service area.

Liquidity and Capital Resources
- -------------------------------

     During the first six months of 1997, the Company continued to suffer
from liquidity difficulties following its emergence from Chapter 11 in July
1996.  While working capital at June 30, 1997 increased by $189,000 (16%) from
December 31, 1996; cash balances decreased by $64,000 due to increased
receivables.  SMC continued its efforts to secure new financing throughout the
first quarter of 1997.  In addition, the Company has made substantial progress
in enhancing its operating cash flows through stringent cost control and
emphasis on targeted marketing of those of its services which attract higher
margins.

Impact of Inflation
- -------------------

     SMC seeks to protect itself from the effects of inflation.  The majority
of contracts the Company performs are for a period of one year or less or are
cost plus fixed-fee type contracts and, accordingly, are less susceptible to
the effects of inflation.  Multi-year contracts provide for projected
increases in labor and other costs.

Subsequent Events
- -----------------

     Effective April 30, 1997, Versar, Inc. acquired 53% of the outstanding
common stock and all outstanding preferred stock of Science Management
Corporation for aggregate consideration of $2,870,000 in cash.  Versar intends
to propose a merger pursuant to which Versar will obtain the remaining SMC
common stock for newly issued shares of Versar common stock,  subject to SMC
stockholder approval.  (See Item 5 - "Other Information" for further details.)
    
                                    
                                    
                                    
          THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK

                                       9

<PAGE>




                       PART II - OTHER INFORMATION
                                    
Item 1.  Legal Proceedings

     Shortly after Science Management Corporation emerged from bankruptcy on
July 10, 1996, disputes arose between its new majority investors, Imperial
Capital Worldwide Partners, L.P. and the management of the Company. 
Subsequently, two lawsuits were instituted against Imperial and its
principals.  On September 6, 1996, two SMC administrative creditors filed a
Complaint for injunctive and other relief entitled  Ravin, Sarashon, Cook,
Baumgarten, Fisch & Rosen, P.C. and Shanley & Fisher, P.C. v. Imperial
Worldwide Partners, L.P. et al. Case No. 93-34553 in the United States
Bankruptcy Court, District of New Jersey, to restrain certain actions by
Imperial and its principals and to designate James A. Skidmore, Jr. as the
manager of the Company to operate the Company on a day to day basis and carry
out the terms of the Plan of Reorganization.  On November 6, 1996, James
A.Skidmore, Jr. and other management shareholders and certain unsecured
creditor shareholders filed a Complaint against Imperial entitled - James A.
Skidmore, Jr. et al. v. Imperial Capital Worldwide Partners, L.P. et al.
Docket No. MON C 278-96 in the  Superior Court of New Jersey, Monmouth County,
Chancery Division seeking an injunction against Imperial and its principals to
rescind certain Board of Directors actions and enjoin their interference with
Mr. Skidmore s day to day management of the Company.  

     As part of the Stock Purchase Agreement dated April 30, 1997 between
Versar, Inc. and Imperial Worldwide Partners, L.P. it was agreed that the
Plaintiffs and the Defendants in the two above cited proceedings would execute
mutual releases from further liability and agree to enter into Stipulations of
Dismissal for both actions.  The Mutual Releases have been signed by all but
four plaintiffs in the Skidmore case, (who are expected to sign in the next
few days), at which time Stipulations of Dismissal will be filed in the
appropriate courts.

     In June 1996, Flintlock Ltd, a client of SMC McEver, a subsidiary of the
Company, filed an action in the 165th Judicial District Court of Harris
County, Texas, entitled Flintlock Ltd. v. SMC McEver, Inc., Case No. 96-
002700.  Flintlock alleged that SMC McEver negligently failed to manage the
construction of a citronella candle project and negligently misrepresented the 
project s cost.  Flintlock asserts that it incurred over $700,000 in damages. 
SMC McEver has counterclaimed for over $244,000 which it claims is due under
the contract between the parties.  The parties have taken certain discovery
which remains ongoing.   The parties have also engaged in discussions
regarding possible mediation.

     SMC McEver has retained counsel and is defending this matter vigorously. 
The management of the Company is evaluating the Company s defenses and
potential exposure.

     SMC and its subsidiaries are parties to various other legal actions
arising in the normal course of business.  The Company believes that the
ultimate unfavorable resolution of these other legal actions will not have a
material adverse affect on its consolidated financial condition and results of
operations.

Item 5.  Other Information

     Science Management Corporation filed for bankruptcy on July 28, 1993. 
The Company emerged from bankruptcy on July 10, 1996 as a result of an
investment by Imperial Capital Worldwide Partners, L.P. in exchange for
approximately 53% of the outstanding newly issued Common Stock, 100% of the
newly issued preferred stock of the Company and certain options to purchase
350,000 additional shares of outstanding common stock from other shareholders
of the Company.  Since that time the Company has continued to suffer financial
difficulty.  After emerging from bankruptcy, the Company has not had the
financial resources to

                                 10

<PAGE>



                  PART II - OTHER INFORMATION (continued)

Item 5.  Other Information (continued)

maintain its periodic reporting under the Securities Exchange Act of 1934, as
amended.  Further, shortly after the Company emerged from bankruptcy, its new
majority investors were sued in state and bankruptcy courts by certain
management stockholders, other stockholders and two of the Company s
administrative creditors.  See Item 1, Legal Proceedings.  The limited
resources of the Company were monopolized by this litigation.

     On May 2, 1997, pursuant to a Stock Purchase Agreement dated April 30,
1997, Versar, Inc. ( Versar ) purchased from Imperial Capital Worldwide
Partners, L.P., a Delaware limited partnership ( Imperial ) 1,070,000 shares
of common stock of the Company (representing approximately 53% of the issued
and outstanding common stock of the Company), 100% of the issued and
outstanding preferred stock of the Company and certain options to purchase
350,000 additional shares of the Company s common stock for an aggregate
purchase price of $2,790,000 paid in cash.  As additional consideration for
such stock purchases, Versar paid certain legal fees incurred by Imperial and
its affiliates in connection with the stock purchase and other matters related
to the Company in an aggregate amount of $80,000.

     At the same time, Versar entered into an Agreement to Merge with James
A. Skidmore, Jr., Chairman and CEO of the Company and certain other management
shareholders.  Pursuant to this Agreement,  Versar presently intends to
propose a merger pursuant to which the Company will be merged into a
subsidiary of Versar and the remaining shares of Company s common stock not
held by Versar will be exchanged for newly issued shares of the Versar s
common stock, subject to the negotiation of a definitive merger agreement by
the Company and Versar.

     On May 2, 1997, pursuant to the Stock Purchase Agreement, Harvey Borsuk,
Jonathan Borsuk and Michelle Borsuk Dana resigned as director s of the Company
and Benjamin M. Rawls, Lawrence W. Sinnott and James C. Dobbs, Chairman and
CEO, Vice President and CFO and Vice President and General Counsel
respectively of Versar were elected to the Company s Board of Directors.

Item 6 -  Exhibits and Reports on Form 8-K

     (a)  Exhibits
          Exhibit 27 - Financial Data Schedules

     (b)  Reports on Form 8-K
          None


                                    11

<PAGE>



                                SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.





                                      
                                        SCIENCE MANAGEMENT CORPORATION
                                        ------------------------------
                                                  (Registrant)






                                        By:   /s/  James A. Skidmore, Jr.
                                           -----------------------------------
                                           James A. Skidmore, Jr.
                                           President and Chief Executive
                                           Officer
                                      










Date:  August 19, 1997
 
                                    12

<PAGE>


<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                             342
<SECURITIES>                                         0
<RECEIVABLES>                                    5,559
<ALLOWANCES>                                       279
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 5,770
<PP&E>                                           1,961
<DEPRECIATION>                                   1,590
<TOTAL-ASSETS>                                   7,231
<CURRENT-LIABILITIES>                            4,373
<BONDS>                                              0
                                0
                                      1,750
<COMMON>                                           200
<OTHER-SE>                                       (102)
<TOTAL-LIABILITY-AND-EQUITY>                     7,231
<SALES>                                              0
<TOTAL-REVENUES>                                12,429
<CGS>                                                0
<TOTAL-COSTS>                                   12,220
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    209
<INCOME-TAX>                                        18
<INCOME-CONTINUING>                                191
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       191
<EPS-PRIMARY>                                     0.10
<EPS-DILUTED>                                     0.10
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission